幹細胞バンクの世界市場：臍帯血バンク、コード組織バンク...市場調査レポートについてご紹介

1 Introduction (Page No. – 12)
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 15)
2.1 Research Data
2.1.1 Key Data From Secondary Sources
2.1.2 Key Data From Primary Sources
2.1.2.1 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.4.1 Assumptions

3 Executive Summary (Page No. – 23)

4 Premium Insights (Page No. – 25)
4.1 Attractive Opportunities in the Stem Cell Banking Market

5 Market Overview (Page No. – 28)
5.1 Market Segmentation
5.1.1 Stem Cell Banking, By Bank Type
5.1.2 Stem Cell Banking, By Service
5.1.3 Stem Cell Banking, By Application
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Easy Extraction Methods
5.2.1.2 Rising Number of Newborns
5.2.1.3 Growth in Gdp, Disposable Income, and Increased Awareness of Stem Cell Therapeutics
5.2.1.4 Potential of Stem Cells in Disease Treatment
5.2.2 Restraints
5.2.2.1 High Competition in the Stem Cell Banking Market
5.2.2.2 High Operating Cost
5.2.2.3 Lack of Acceptance
5.2.2.4 Changes in Legal Regulations
5.2.3 Opportunities
5.2.3.1 Rising Awareness About Potential Use of Cord Tissue
5.2.3.2 Collaborations Among Cord Blood Banks
5.2.3.3 The Automation of Procedures
5.2.4 Challenges
5.2.4.1 Entry Barriers in the Market

6 Stem Cell Banking Market, By Bank Type (Page No. – 34)
6.1 Introduction
6.2 Cord Blood
6.3 Cord Tissue

7 Stem Cell Banking Market, By Service (Page No. – 43)
7.1 Introduction
7.2 Collection & Transportation
7.3 Processing
7.4 Analysis
7.5 Storage

8 Stem Cell Banking Market, By Application (Page No. – 52)
8.1 Introduction
8.2 Cerebral Palsy
8.3 Thalassemia
8.4 Leukemia
8.5 Diabetes
8.6 Autism
8.7 Others

9 Stem Cell Banking Market, By Region (Page No. – 67)
9.1 Introduction
9.2 North America
9.2.1 North America, By Country
9.2.2 North America, By Type
9.2.3 North America, By Service
9.2.4 North America, By Application
9.3 Europe
9.3.1 Europe, By Country
9.3.2 Europe, By Type
9.3.3 Europe, By Service
9.3.4 Europe, By Application
9.4 Asia-Pacific
9.4.1 Asia-Pacific, By Country
9.4.2 Asia-Pacific, By Type
9.4.3 Asia-Pacific, By Service
9.4.4 Asia-Pacific, By Application
9.5 Rest of The World (RoW)
9.5.1 Rest of the World, By Type
9.5.2 Rest of the World, By Service
9.5.3 Rest of the World, By Application

10 Competitive Landscape (Page No. – 85)
10.1 Company Share Analysis
10.2 New Service/Product Launches
10.3 Mergers & Acquisitions
10.4 Regulatory Approvals
10.5 Partnerships
10.6 Joint Venture
10.7 Agreements
10.8 Collaborations
10.9 Technological Update
10.10 Patent
10.11 Geographical Expansion
10.12 Others

11 Company Profile (Page No. – 91)
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
11.1 CBR Systems, Inc.
11.2 Cordlife
11.3 Cryo-Cell
11.4 Cryo-Save AG (A Group of Esperite)
11.5 Lifecell
11.6 Stemcyte
11.7 Viacord
11.8 Smart Cells International Ltd.
11.9 Cryoviva India
11.10 Cordvida
11.11 China Cord Blood Corporation

*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 112)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports